Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HLE3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.599 |
DEG_SCF_FBW7_2 | 6 | 13 | PF00400 | 0.564 |
DOC_CKS1_1 | 7 | 12 | PF01111 | 0.552 |
DOC_WW_Pin1_4 | 6 | 11 | PF00397 | 0.582 |
LIG_14-3-3_CanoR_1 | 26 | 33 | PF00244 | 0.585 |
LIG_APCC_ABBA_1 | 8 | 13 | PF00400 | 0.550 |
LIG_BRCT_BRCA1_1 | 34 | 38 | PF00533 | 0.426 |
LIG_FHA_1 | 35 | 41 | PF00498 | 0.507 |
LIG_FHA_1 | 44 | 50 | PF00498 | 0.470 |
LIG_FHA_2 | 7 | 13 | PF00498 | 0.490 |
LIG_FHA_2 | 86 | 92 | PF00498 | 0.551 |
LIG_LIR_Gen_1 | 16 | 27 | PF02991 | 0.424 |
LIG_LIR_Gen_1 | 47 | 58 | PF02991 | 0.459 |
LIG_LIR_Gen_1 | 78 | 89 | PF02991 | 0.538 |
LIG_LIR_Nem_3 | 16 | 22 | PF02991 | 0.453 |
LIG_LIR_Nem_3 | 78 | 84 | PF02991 | 0.537 |
LIG_Pex14_1 | 81 | 85 | PF04695 | 0.407 |
LIG_SH2_CRK | 19 | 23 | PF00017 | 0.506 |
LIG_SH2_GRB2like | 21 | 24 | PF00017 | 0.599 |
LIG_SH2_SRC | 21 | 24 | PF00017 | 0.543 |
LIG_SH2_STAP1 | 11 | 15 | PF00017 | 0.568 |
LIG_SH2_STAT3 | 62 | 65 | PF00017 | 0.560 |
LIG_SH2_STAT5 | 21 | 24 | PF00017 | 0.599 |
LIG_SH2_STAT5 | 50 | 53 | PF00017 | 0.486 |
LIG_SH3_3 | 1 | 7 | PF00018 | 0.561 |
LIG_TRAF2_1 | 10 | 13 | PF00917 | 0.581 |
MOD_CK1_1 | 34 | 40 | PF00069 | 0.287 |
MOD_CK2_1 | 6 | 12 | PF00069 | 0.501 |
MOD_CK2_1 | 85 | 91 | PF00069 | 0.539 |
MOD_GlcNHglycan | 102 | 105 | PF01048 | 0.390 |
MOD_GlcNHglycan | 28 | 31 | PF01048 | 0.433 |
MOD_GlcNHglycan | 77 | 80 | PF01048 | 0.519 |
MOD_GSK3_1 | 48 | 55 | PF00069 | 0.466 |
MOD_GSK3_1 | 85 | 92 | PF00069 | 0.535 |
MOD_N-GLC_1 | 13 | 18 | PF02516 | 0.557 |
MOD_N-GLC_1 | 75 | 80 | PF02516 | 0.524 |
MOD_N-GLC_1 | 85 | 90 | PF02516 | 0.543 |
MOD_NEK2_1 | 32 | 37 | PF00069 | 0.433 |
MOD_NEK2_1 | 52 | 57 | PF00069 | 0.465 |
MOD_NEK2_1 | 85 | 90 | PF00069 | 0.543 |
MOD_PKA_2 | 53 | 59 | PF00069 | 0.470 |
MOD_Plk_1 | 85 | 91 | PF00069 | 0.597 |
MOD_Plk_4 | 48 | 54 | PF00069 | 0.465 |
MOD_ProDKin_1 | 6 | 12 | PF00069 | 0.577 |
MOD_SUMO_rev_2 | 67 | 74 | PF00179 | 0.422 |
TRG_DiLeu_BaEn_1 | 48 | 53 | PF01217 | 0.486 |
TRG_ENDOCYTIC_2 | 19 | 22 | PF00928 | 0.507 |
TRG_ENDOCYTIC_2 | 50 | 53 | PF00928 | 0.486 |
TRG_Pf-PMV_PEXEL_1 | 42 | 47 | PF00026 | 0.450 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I217 | Leptomonas seymouri | 68% | 100% |
A0A0S4JGU8 | Bodo saltans | 58% | 98% |
A0A1X0P0S4 | Trypanosomatidae | 60% | 100% |
A0A3Q8IDN3 | Leishmania donovani | 91% | 100% |
A0A422P2N7 | Trypanosoma rangeli | 60% | 100% |
A4I8V2 | Leishmania infantum | 91% | 100% |
D0A4U8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 97% |
E9B3S1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q4Q4A3 | Leishmania major | 89% | 100% |